Annual Shareholders Equity
$90.83 M
-$11.99 M-11.67%
30 September 2023
Summary:
Citius Pharmaceuticals annual stockholders equity is currently $90.83 million, with the most recent change of -$11.99 million (-11.67%) on 30 September 2023. During the last 3 years, it has fallen by -$41.35 million (-31.28%). CTXR annual shareholders equity is now -31.28% below its all-time high of $132.18 million, reached on 30 September 2021.CTXR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$85.68 M
+$6.32 M+7.96%
30 June 2024
Summary:
Citius Pharmaceuticals quarterly stockholders equity is currently $85.68 million, with the most recent change of +$6.32 million (+7.96%) on 30 June 2024. Over the past year, it has dropped by -$5.15 million (-5.67%). CTXR quarterly shareholders equity is now -37.31% below its all-time high of $136.68 million, reached on 30 June 2021.CTXR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTXR Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -5.7% |
3 y3 years | -31.3% | -35.2% |
5 y5 years | +234.5% | +215.6% |
CTXR Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -31.3% | at low | -35.2% | +8.0% |
5 y | 5 years | -31.3% | +234.5% | -37.3% | +320.5% |
alltime | all time | -31.3% | >+9999.0% | -37.3% | +5488.3% |
Citius Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $85.68 M(+8.0%) |
Mar 2024 | - | $79.37 M(-6.3%) |
Dec 2023 | - | $84.73 M(-6.7%) |
Sept 2023 | $90.83 M(-11.7%) | $90.83 M(-7.0%) |
June 2023 | - | $97.70 M(+7.1%) |
Mar 2023 | - | $91.21 M(-9.2%) |
Dec 2022 | - | $100.43 M(-2.3%) |
Sept 2022 | - | $102.83 M(-6.3%) |
Sept 2022 | $102.83 M(-22.2%) | - |
June 2022 | - | $109.74 M(-6.7%) |
Mar 2022 | - | $117.60 M(-5.1%) |
Dec 2021 | - | $123.96 M(-6.2%) |
Sept 2021 | $132.18 M(+292.6%) | $132.18 M(-3.3%) |
June 2021 | - | $136.68 M(+9.2%) |
Mar 2021 | - | $125.16 M(+396.7%) |
Dec 2020 | - | $25.20 M(-25.2%) |
Sept 2020 | $33.67 M(+24.0%) | $33.67 M(+17.1%) |
June 2020 | - | $28.74 M(+28.1%) |
Mar 2020 | - | $22.44 M(+10.1%) |
Dec 2019 | - | $20.38 M(-25.0%) |
Sept 2019 | $27.15 M(-2.6%) | $27.15 M(+26.3%) |
June 2019 | - | $21.51 M(+3.0%) |
Mar 2019 | - | $20.87 M(-13.7%) |
Dec 2018 | - | $24.18 M(-13.2%) |
Sept 2018 | $27.87 M | $27.87 M(+28.8%) |
June 2018 | - | $21.64 M(-7.9%) |
Mar 2018 | - | $23.50 M(-9.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | - | $25.86 M(+17.8%) |
Sept 2017 | $21.95 M(+30.9%) | $21.95 M(+89.3%) |
June 2017 | - | $11.59 M(-17.1%) |
Mar 2017 | - | $13.99 M(-7.7%) |
Dec 2016 | - | $15.16 M(-9.6%) |
Sept 2016 | $16.77 M(-2739.5%) | $16.77 M(-7.7%) |
June 2016 | - | $18.16 M(-11.1%) |
Mar 2016 | - | $20.43 M(-1384.5%) |
Dec 2015 | - | -$1.59 M(+150.3%) |
Sept 2015 | -$635.20 K(-14.4%) | -$635.20 K(-46.2%) |
June 2015 | - | -$1.18 M(+28.6%) |
Mar 2015 | - | -$918.00 K(+11.5%) |
Dec 2014 | - | -$823.50 K(+11.0%) |
Sept 2014 | -$741.90 K(+4946.9%) | -$741.90 K(+2262.7%) |
June 2014 | - | -$31.40 K(+25.1%) |
Mar 2014 | - | -$25.10 K(+67.3%) |
Dec 2013 | - | -$15.00 K(+2.0%) |
Sept 2013 | -$14.70 K(-67.9%) | -$14.70 K(-76.3%) |
June 2013 | - | -$61.90 K(+7.7%) |
Mar 2013 | - | -$57.50 K(+21.6%) |
Dec 2012 | - | -$47.30 K(+3.3%) |
Sept 2012 | -$45.80 K(+92.4%) | -$45.80 K(+13.1%) |
June 2012 | - | -$40.50 K(+20.5%) |
Mar 2012 | - | -$33.60 K(+27.3%) |
Dec 2011 | - | -$26.40 K(+10.9%) |
Sept 2011 | -$23.80 K | -$23.80 K(+12.8%) |
June 2011 | - | -$21.10 K |
FAQ
- What is Citius Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Citius Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CTXR is $90.83 M
What is the all time high annual shareholders equity for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual stockholders equity is $132.18 M
What is Citius Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CTXR is $85.68 M
What is the all time high quarterly shareholders equity for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly stockholders equity is $136.68 M
What is Citius Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CTXR quarterly stockholders equity has changed by -$5.15 M (-5.67%)